BIOCHIP 检测在大疱性类天疱疮、寻常天疱疮和落叶天疱疮诊断中的验证
该研究评估了新型多重间接免疫荧光技术 BIOCHIP 在大疱性类天疱疮(BP)、寻常天疱疮(PV)和落叶天疱疮(PF)中的诊断准确性,使用患者及对照血清,并与直接免疫荧光、间接免疫荧光和 ELISA 比较。结果显示 BIOCHIP 对 BP180/BP230 在 BP 中灵敏度 86.8%、特异度 85%,对 Dsg1 在 PF 中灵敏度 75%、特异度 97.7%,对 Dsg3 在 PV 中灵敏度 60.9%、特异度 73.6%。结论认为 BIOCHIP 可能是一种简便省时的辅助诊断工具,但需考虑判读偏倚和学习曲线。
要点
- BIOCHIP 对 BP 的 BP180/BP230 灵敏度 86.8%、特异度 85%。
- BIOCHIP 对 PF 的 Dsg1 灵敏度 75%、特异度 97.7%。
- BIOCHIP 对 PV 的 Dsg3 灵敏度 60.9%、特异度 73.6%。
核心结论
- BIOCHIP 多重免疫荧光检测可能是一种简便、省时的工具,有助于 BP、PV 和 PF 的诊断与筛查,但需考虑判读偏倚和学习曲线。
研究设计与样本
- 验证性研究,使用 BP 患者血清 38 例、PF 患者 8 例、PV 患者 23 例,疾病对照 63 例和健康志愿者 39 例。
- 所有 BP、PF 和 PV 患者均进行 BIOCHIP 多重检测和直接免疫荧光(DIF);BP 患者额外进行间接免疫荧光(IIF),天疱疮患者进行 ELISA。
主要发现
- BIOCHIP 对 BP 中 BP180 或 BP230 阳性的灵敏度为 86.8%,特异度为 85%。
- BIOCHIP 对 PF 中 Dsg1 的灵敏度为 75%,特异度为 97.7%。
- BIOCHIP 对 PV 中 Dsg3 的灵敏度为 60.9%,特异度为 73.6%。
临床怎么用
- BIOCHIP 可作为 BP、PV 和 PF 的辅助诊断与筛查工具,但判读时需注意偏倚并考虑学习曲线。
局限性
- 存在判读偏倚的可能,且需要学习曲线。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The BIOCHIP is a novel multiplex indirect immunofluorescence technique used in the serological diagnosis of bullous pemphigoid and pemphigus. The BIOCHIP method combines the screening of autoantibodies and target antigen-specific substrates in a single miniature incubation field. OBJECTIVE: To evaluate the diagnostic accuracy of the new immunofluorescence BIOCHIP multiplex tool in pemphigus and bullous pemphigoid. METHODS: For the validation of the BIOCHIP, sera from patients with BP (n = 38), PF (n = 8) and pemphigus vulgaris (PV) (n = 23) were used. In addition, sera from disease control patients (n = 63) and healthy volunteers (n = 39) were used. The multiplex BIOCHIP and direct immunofluorescence (DIF) were performed for all BP, PF and PV patients. Additional indirect immunofluorescence (IIF) was performed on patients with BP, and ELISA was performed on patients with pemphigus. RESULTS: The BIOCHIP mosaic showed a sensitivity of 86.8% and specificity of 85% for BP180 or BP230 being positive in BP. It demonstrated a sensitivity of 75% and specificity of 97.7% for Dsg1 in PF. The BIOCHIP was found to have a sensitivity of 60.9% and specificity of 73.6% for Dsg3 in PV. CONCLUSION: The BIOCHIP mosaic-based immunofluorescence test is potentially a simple, time and effort saving test that can aid in the diagnosis and screening of BP, PV and PF. However, there is potential for interpretation bias and a learning curve that needs to be taken into consideration.
引用
- Yang A, Xuan R, Melbourne W, et al. Validation of the BIOCHIP test for the diagnosis of bullous pemphigoid, pemphigus vulgaris and pemphigus foliaceus. J Eur Acad Dermatol Venereol. 2019. PMID: 31260565. doi:10.1111/jdv.15770
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。